Mol Metab (2023) 68:101665
Women experiencing low sexual desire: One of the few clinically studied options for female sexual dysfunction
Even so, the pill's launch has done little to boost Novo's stock price, as the Danish drugmaker is struggling to win back market share from Lilly in the broader obesity space and convince investors that its drug pipeline can help it grow beyond its existing products
Conchillo M, De Knegt RJ, Payeras M, Quiroga J, Sangro B, Herrero JI, Castilla-Cortazar I, Frystyk J, Flyvbjerg A, Yoshizawa C, Jansen PLM, Scharschmidt B, Prieto J
Additionally, the presence of CKD, whether pre-existing or newly developed post-transplant, compounds the challenges faced by these patients, creating a double hit scenario that further complicates their management